GlassScriptPhysician profile
Aaron Lee Scaife
NPI 1093929374
$1,040.00
in general payments reported to CMS, 2019-2025
12 companies · $686 in 2025
The $686 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2021: $23.31 · 2022: $99.56 · 2023: $29.64 · 2025: $686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $257.48 | 2022-2025 | Evenity, Prolia |
| Abbvie INC. | $195.33 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $142.55 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $117.39 | 2025 | Exparel |
| Biogen, INC. | $101.57 | 2025 | Zurzuvae |
| Medical Device Business Services, INC. | $86.66 | 2019 | |
| Organon LLC | $34.42 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $26.74 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.34 | 2023 | |
| Ethicon US, LLC | $23.31 | 2021 | |
| Evofem Biosciences, INC. | $19.01 | 2022 | |
| Amag Pharmaceuticals, INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Scaife listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.